Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.736
-0.006 (-0.86%)
At close: Jun 26, 2026, 4:00 PM EDT
0.770
+0.034 (4.63%)
Pre-market: Jun 29, 2026, 7:06 AM EDT
RANI Employees
As of December 31, 2025, Rani Therapeutics Holdings had 71 total employees, including 69 full-time and 2 part-time employees. The number of employees decreased by 35 or -33.02% compared to the previous year.
Employees
71
Change (1Y)
-35
Growth (1Y)
-33.02%
Revenue / Employee
$44,634
Profits / Employee
-$414,676
Market Cap
91.17M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Seer, Inc. | 124 |
| Inovio Pharmaceuticals | 112 |
| Fortress Biotech | 78 |
| PolyPid | 75 |
| ImmuCell | 73 |
| NeurAxis | 24 |
| LeonaBio | 19 |
RANI News
- 4 weeks ago - Rani Therapeutics Holdings Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 6 weeks ago - Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition - GlobeNewsWire
- 6 weeks ago - Rani Therapeutics Holdings Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Rani Therapeutics Holdings Earnings release: Q1 2026 - Filings
- 6 weeks ago - Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference - GlobeNewsWire
- 2 months ago - Rani Therapeutics Holdings Proxy statement: Proxy filing - Filings
- 2 months ago - Rani Therapeutics Holdings Proxy statement: Proxy filing - Filings